KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Shareholders’ Approval of “Going Private” Transaction Approximately 62.91% of the Company’s total outstanding shares, representing approximately 71.92% of the voting rights of the Company’s shares, voted in person or by proxy at the EGM. If the Merger is completed, the Company will b]

CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)

[1 Announcement dated August 17, 2018 in respect of Appointment of Executive Directors. build-out • the Company’s ability to effectively sustain its growth and to achieve or enhance profitability; • • changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommu]

By | 2018-08-20T12:06:34+00:00 August 20th, 2018|Categories: Chinese Stocks, CHU, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: SEC Concludes Investigation of Sinovac About Sinovac Sinovac

[SEC Concludes Investigation of Sinovac About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccine]

By | 2018-08-21T03:36:34+00:00 August 20th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] 6-K: iKang Announces Shareholders’ Approval of “Going Private” Transaction

[iKang Announces Shareholders’ Approval of “Going Private” Transaction Approximately 62.91% of the Company’s total outstanding shares, representing approximately 71.92% of the voting rights of the Company’s shares, voted in person or by proxy at the EGM. If the Merger is completed, the Company will b]

CHU [CHINA UNICOM (HONG KONG)] 6-K: 1 Announcement dated August 17, 2018 in respect

[1 Announcement dated August 17, 2018 in respect of Appointment of Executive Directors. build-out • the Company’s ability to effectively sustain its growth and to achieve or enhance profitability; • • changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommu]

By | 2018-08-20T12:06:40+00:00 August 20th, 2018|Categories: Chinese Stocks, CHU, Webplus ver|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: (Original Filing)

[Major Shareholders of China Automotive Systems Announce Withdrawal WUHAN, China, August 20, 2018 — China Automotive Systems, Inc. (NASDAQ: CAAS) In a letter dated August 30, 2017 from Mr. Hanlin Chen, chairman of the Company, and his affiliates, including Wiselink Holdings Limited, a company control]

By | 2018-08-20T12:01:09+00:00 August 20th, 2018|Categories: CAAS, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] SC 13D: (Original Filing)

[JOINT FILING AGREEMENT [Remainder of Page Intentionally Left Blank] GL Trade Investment Limited Hu Chou Hui Director GL China Opportunities Fund L.P. Zhenfu Li Authorized Signatory GL Capital Management GP L.P. Zhenfu Li Authorized Signatory GL Capital Management GP Limited Zhenfu Li Director GL Par]

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: Major Shareholders of China Automotive Systems Announce Withdrawal

[Major Shareholders of China Automotive Systems Announce Withdrawal WUHAN, China, August 20, 2018 — China Automotive Systems, Inc. (NASDAQ: CAAS) In a letter dated August 30, 2017 from Mr. Hanlin Chen, chairman of the Company, and his affiliates, including Wiselink Holdings Limited, a company control]

By | 2018-08-20T12:01:14+00:00 August 20th, 2018|Categories: CAAS, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] SC 13D: JOINT FILING AGREEMENT [Remainder of Page Intentionally Left

[JOINT FILING AGREEMENT [Remainder of Page Intentionally Left Blank] GL Trade Investment Limited Hu Chou Hui Director GL China Opportunities Fund L.P. Zhenfu Li Authorized Signatory GL Capital Management GP L.P. Zhenfu Li Authorized Signatory GL Capital Management GP Limited Zhenfu Li Director GL Par]

VNET [21Vianet] 6-K: (Original Filing)

[21Vianet Group, Inc. Reports Unaudited Second Quarter 2018 Financial Results Adjusted EBITDA up 103.6% YoY to RMB221.1 million Adjusted EBITDA margin expanded to 26.7% Raised full year guidance for both net revenues and adjusted EBITDA Dial-in BEIJING, August 17, 2018 (GLOBE NEWSWIRE) — 21Vianet Gro]

Skip to toolbar